Abstract submission:

Final Abstract Submission Deadline: March 1, 2025
Abstract Acceptance Notification: March 31, 2025

Rules and regulations: Only one paper or poster may be read or presented by the same author at the Meeting, although a presenter may be a co-author of any number of papers. The material must not have been published prior to submission of the abstract. Simultaneous submission of the same abstract to other meetings is prohibited.

Publication of abstracts: The abstracts will also be available via links on the ASPCR 2025 website approximately late March/early April 2025.

Presentation: After the abstract submission deadline, all abstracts will be reviewed by the 2025 ASPCR Committee on Scientific Programs.

Abstracts can be programmed into the following session types:

（1）Vitiligo（basic）

（2）Vitiligo（clinical）

（3）Hyperpigmentary Disorders

（4）Melanoma

（5）Others

Type of presentation: Oral presentation or poster presentation

Abstract Formatting and Content Guidelines:

*You must be registered for the meeting to have your abstract considered for a presentation.
Language: English
Authors: full last name, first name, affiliations, degrees and contact information. BOLD the name of the Presenting Author and include the Presenting Author’s contact information.
Font: Arial

Abstract text should preferably be in a "structured abstract" form with sections marked Background, Objectives, Methods, Results, and Conclusions

Maximum of 2300 characters, including spaces (not including the title, authors, or affiliations)
Full contact information of corresponding author (Please ensure that your email address is accurate, as all correspondence will be sent via email)
Abstracts containing non-generic drug names or personal patient information, or reporting studies with unidentified chemical compounds, drugs, or materials, will not be accepted.